hemolytic anemia
MeSH: D000743ORPHA: 983631 Treatment Available
Overview
form of anemia due to hemolysis
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| mitapivat Orphan | Oral tablet, 5mg, 20mg, 50mg | FDA Approved (2022), EMA Approved (2022) | 5 | 10d |
Classification & Codes
MeSH Code
D000743Orphanet Code
ORPHA:98363hemolytic anemia
| MeSH | D000743 |
| Orphanet | ORPHA:98363 |
| Treatments | 1 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO